Ertl-Wagner B, Brandt T, Seifart C, Forsting M. Diagnostic and thera- peutic consequences of repeat brain imaging and follow-up vascular im- aging in stroke patients. AJNR Am J Neuroradiol. 1999;20:37 42. 310. Schneider LB, Libman RB, Kanner R. Utility of repeat brain imaging in stroke. AJNR Am J Neuroradiol. 1996;17:1259 1263. 311. S ndergaard L, Kasner SE, Rhodes JF, Andersen G, Iversen HK, Nielsen-KudskJE,SettergrenM,Sj strandC,RoineRO,Hildick-SmithD, et al; Gore REDUCE Clinical Study Investigators. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med. 312. Mas JL, Derumeaux G, Guillon B, Massardier E, Hosseini H, Mechtouff L, Arquizan C, B jot Y, Vuillier F, Detante O, et al; CLOSE Investigators. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med. 2017;377:1011 1021. doi: 313. Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA, Marks DS, Tirschwell DL; RESPECT Investigators. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J 314. Saver JL, Carroll JD, Thaler DE, Smalling RW, MacDonald LA, Marks DS, Tirschwell DL; RESPECT Investigators. Long-term out- comes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med. 2017;377:1022 1032. doi: 10.1056/NEJMoa1610057 315. Meier B, Kalesan B, Mattle HP, Khattab AA, Hildick-Smith D, Dudek D, AndersenG,IbrahimR,SchulerG,WaltonAS,etal;PCTrialInvestigators. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med. 2013;368:1083 1091. doi: 10.1056/NEJMoa1211716 316. Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, Felberg R, Herrmann H, Kar S, Landzberg M, et al; CLOSURE I Investigators. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012;366:991 999. doi: 317. Lee PH, Song JK, Kim JS, Heo R, Lee S, Kim DH, Song JM, Kang DH, Kwon SU, Kang DW, et al. 